MINNEAPOLIS – June 20, 2019 – Vireo Health International, Inc. (“Vireo” or the “Company”) (CSE: VREO), a leading physician-led, science-focused multi-state cannabis company, today announced the acquisition of medical cannabis licenses in the Commonwealth of Puerto Rico. The acquisition is comprised of pre-approvals for licenses to cultivate, process, and sell cannabis products and operate up to six dispensaries. This transaction marks the eleventh market in which Vireo is licensed to grow, manufacture, or sell cannabis products. “Vireo continues to seek...
Read more
Vireo Health Expands into Puerto Rico’s Rapidly Growing Medical Cannabis Market
Harris Rabin, former ABInBev & Bayer leader, joins Vireo Health as Chief Marketing Officer
Rabin brings two decades of marketing and innovation experience in consumer healthcare and beverage alcohol industries NEW YORK, May 28, 2019 – Vireo Health International, Inc., a leading science-focused, multi-state...
Read more
Autism and Cannabis: Can it Help Manage Symptoms?
Most of us know a family that is impacted by autism spectrum disorder (ASD). It’s a devastating, yet common condition with around 1 in 59 children diagnosed in 2018. There...
Read more
The Facts About Cannabis: Why is Vaporization Better than Smoking?
As cannabis continues to permeate the mainstream, it’s forcing a perspective shift for many of us who once felt uncomfortable even discussing marijuana. And one of the areas in which...
Read more
VIREO HEALTH ANNOUNCES BOARD OF DIRECTORS
Company establishes U.S. governance standards with appointment of new directors and committees MINNEAPOLIS — May 16, 2019 – Vireo Health International, Inc. ("Vireo Health" or the "Company") (CSE: VREO), a...
Read more View More >